Vital dye analysis of cranial neural crest cell migration in the mouse embryo by Serbedzija, George N. et al.
Introduction
In vertebrate embryos, cranial neural crest cells arise from
the lateral edges of the neural folds, at the juncture of the
neuroectoderm and the ectoderm (Horstadius, 1950; Ver-
meij-keers and Poelmann, 1980; Nichols, 1981, 1986, 1987;
Tosney, 1982). In chicken embryos, ultrastructural studies
suggest that emigration of cranial neural crest cells from
the neural tube begins shortly after fusion of the neural folds
(Tosney, 1982). The pathways of cranial neural crest cell
migration have been studied most thoroughly in avian
embryos using surgically created chimeric embryos (John-
ston, 1966; Le Douarin, 1982; Noden, 1988). These studies
indicate that cranial neural crest cells migrate along a subec-
todermal pathway that extends ventrolaterally from the
dorsal portion of the neural tube between the ectoderm and
the underlying mesodermal mesenchyme. After migration,
cranial neural crest cells give rise to a variety of craniofa-
cial tissues (Johnston, 1966; Noden, 1975, 1983; Le
Douarin, 1982; Tosney, 1982), including the sensory and
parasympathetic ganglia, cartilage, bone, muscles and con-
nective tissue of the face (Le Douarin, 1982; Noden, 1983).
In the mouse, a variety of genetic mutations exist that
appear to affect neural crest cell migration and differen-
tiation (Gruneberg and Truslove, 1960; Auerbach, 1954; see
review by Morrison-Graham and Weston, 1989). By com-
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The spatial and temporal aspects of cranial neural crest
cell migration in the mouse are poorly understood
because of technical limitations. No reliable cell mark-
ers are available and vital staining of embryos in cul-
ture has had limited success because they develop nor-
mally for only 24 hours. Here, we circumvent these
problems by combining vital dye labelling with exo utero
embryological techniques. To define better the nature of
cranial neural crest cell migration in the mouse embryo,
premigratory cranial neural crest cells were labelled by
injecting DiI into the amniotic cavity on embryonic day
8. Embryos, allowed to develop an additional 1 to 5 days
exo utero in the mother before analysis, showed distinct
and characteristic patterns of cranial neural crest cell
migration at the different axial levels. Neural crest cells
arising at the level of the forebrain migrated ventrally
in a contiguous stream through the mesenchyme
between the eye and the diencephalon. In the region of
the midbrain, the cells migrated ventrolaterally as dis-
persed cells through the mesenchyme bordered by the
lateral surface of the mesencephalon and the ectoderm.
At the level of the hindbrain, neural crest cells migrated
ventrolaterally in three subectodermal streams that
were segmentally distributed. Each stream extended
from the dorsal portion of the neural tube into the distal
portion of the adjacent branchial arch. The order in
which cranial neural crest cells populate their deriva-
tives was determined by labelling embryos at different
stages of development. Cranial neural crest cells popu-
lated their derivatives in a ventral-to-dorsal order, sim-
ilar to the pattern observed at trunk levels. In order to
confirm and extend the findings obtained with exo utero
embryos, DiI (1,1-dioctadecyl-3,3,3 ,3 -tetramethylindo-
carbocyanine perchlorate) was applied focally to the
neural folds of embryos, which were then cultured for
24 hours. Because the culture technique permitted
increased control of the timing and location of the DiI
injection, it was possible to determine the duration of
cranial neural crest cell emigration from the neural
tube. Cranial neural crest cell emigration from the
neural folds was completed by the 11-somite stage in the
region of the rostral hindbrain, the 14-somite stage in
the regions of the midbrain and caudal hindbrain and
not until the 16-somite stage in the region of the fore-
brain. At each level, the time between the earliest and
latest neural crest cells to emigrate from the neural tube
appeared to be 9 hours. Some aspects of cranial neural
crest cell migration were similar to those observed in
avian embryos; however, the exact pathways, the timing
and the axial levels that contribute to the neural crest
cells were distinctly different. 
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paring neural crest cell migration and differentiation in
these mutant embryos with that in normal embryos, it may
be possible to learn much about the mechanisms involved
in both processes. Unfortunately, we have only a limited
understanding of cranial neural crest cell migration in the
mouse, owing to the relative inaccessibility of the embryos
to microsurgical and cell marking techniques. Our present
knowledge of the pathways of migration derives from ultra-
structural studies using either cellular morphology (Ver-
woerd and van Oostrom, 1979) or toluidine blue staining
(Nichols, 1981, 1986) to identify neural crest cells. These
studies suggest that cranial neural crest cells complete their
emigration from the neural folds prior to neural tube clo-
sure in the head. Cranial neural crest cells are thought to
migrate ventrolaterally along a subectodermal pathway,
similar to the pathways observed in chick embryos (John-
ston, 1966; Noden, 1975; Le Douarin, 1982). As migration
continues, neural crest cells become indistinguishable, both
morphologically and histologically, from cells of mesoder-
mal origin; therefore, some method for marking neural crest
cells is required in order to study the subsequent stages of
cranial neural crest cell migration.
Cell marking techniques have been used to follow some
aspects of cranial neural crest cell migration. The microin-
jection of gold-conjugated wheat germ agglutinin into the
amniotic cavity of mouse embryos in culture has permitted
the analysis of the early stages of migration (Smits-van
Prooijie et al., 1986; Chan and Tam, 1988). Wheat germ
agglutinin adheres to cell surface glycoconjugates (Gesink
et al., 1983), thus labelling neural crest cells while they are
contiguous with the ectoderm prior to neural tube fusion
(Smits-van Prooijie et al., 1986). Current culturing tech-
niques permitted approximately 24 hours of normal devel-
opment; therefore, this technique was useful for studying
only the first day of cranial neural crest cell migration.
Because of the nature of the label, one cannot rule out the
possibility that it passed unequally to daughter cells or
passed to unlabelled cells (Smits-van Prooije et al., 1986:
Chan and Tam, 1988). Despite these potential limitations,
these experiments clearly suggested that in the mouse, as
in the chicken, cranial neural crest cells from the rostral
hindbrain region migrate ventrolaterally along a subecto-
dermal pathway and populate the trigeminal ganglia and the
first branchial arch (Chan and Tam, 1988). 
Previously, we labelled premigratory trunk neural crest
cells within the neural tube of the mouse embryo by intralu-
menal injection of the fluorescent carbocyanine dye, DiI
(1,1-dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine per-
chlorate; Serbedzija et al., 1990, 1991). Because DiI is
lipid-soluble and hydrophobic, it incorporates nearly irre-
versibly into the plasma membranes of all cells that it con-
tacts (Sims et al., 1974). This dye does not spread from
labelled to unlabelled cells, nor does it appear to have any
adverse effects on neuronal or neural crest cells (Honig and
Hume, 1986; Serbedzija et al., 1989). However, mouse cra-
nial neural crest cells begin migrating prior to the fusion of
the neural folds (Verwoerd and van Oostrom, 1979;
Nichols, 1981, 1986). This makes injection of DiI into the
neural tube inappropriate for labelling this cell population. 
Here, we report experiments performed using a modifi-
cation of the DiI-labelling technique that permits identifi-
cation of premigratory cranial neural crest cells. DiI was
injected into the amniotic cavity of a mouse embryo from
which it labelled all cells in contact with the amniotic fluid,
including the entire ectoderm, the neural plate and the
neural folds. With further development, only the cells of
neural crest and placodal origin become internalized. The
embryos, maintained within the mother, remained attached
to the uterus throughout the experimental period, utilizing
the exo utero technique first developed for work on the limb
(Muneoka et al., 1986). This avoided the limited develop-
mental times over which whole embryo culture gives
normal development and permits the analysis of cranial
neural crest cell migration over extended periods. To con-
firm and refine some aspects of the migration observed in
exo utero embryos, premigratory neural crest cells were
labelled by injecting small amounts of DiI directly into the
forming neural crest of embryos maintained in culture. By
using both the exo utero and the in vitro labelling tech-
niques, it was possible to determine the pathways of neural
crest cell migration, the temporal pattern of neural crest cell
emigration from the neural folds and the order in which
neural crest cells populate their derivatives. While the gen-
eral pattern of cranial neural crest cell migration was sim-
ilar to that observed in avians, important differences were
observed in the origin and the trajectories of the migrating
neural crest cells.
Materials and methods
Animal preparation
Embryos were obtained by mating CD-1 females with BDF-1
males (Charles Rivers). In the evening, male and female mice
were placed in the same cage, but kept separate by a gated parti-
tion. The gate was opened at 6:00 a.m. the following morning and
the male and female mice were allowed to mate for three hours.
The presence of a vaginal plug at the end of the three hour period
was taken to indicate pregnancy, and the time and date that the
gate was opened was designated embryonic day 0 (E0). This
mating scheme reduced the normal variability in the actual time
of mating as well as the range of developmental stages of the
embryos within a litter. On E8, a pregnant female was anesthetized
with avertin, prepared by mixing 0.5 g of 2,2,2-tribromoethanol
(Chemical Dynamics Corporation), 0.31 ml of 2-methyl-2-butanol
(Aldrich) and 39.5 ml of distilled water. The dosage in milliliters
was determined by the formula: dosage = (0.1 + weight of the
mother in grams/50). After deep anesthesia was achieved, the
abdomen was swabbed with 70% ethanol and the uterus was sur-
gically exposed. An incision was made in the wall of the uterus
on the side opposite the uterine arteries. After the uterus was
opened, the mothers were placed in a 37oC hood, where all sub-
sequent manipulations took place. 
Those embryos to be used for experiments in culture were
removed and placed in dissecting medium consisting of 20% fetal
bovine serum (Hyclone), 79% Dulbecco’s modified Eagle’s
medium (DMEM, Whittaker’s Bioproducts) and 1% penicillin-
streptomyocin L-glutamine (GPS, Whittaker’s Bioproducts) at
37oC. These embryos were dissected to detach partially their
extraembryonic membranes, but both the embryo and the extraem-
bryonic membranes were left attached to the placenta for the entire
culture period.
Embryos that were allowed to develop in the mother (exo utero
embryos) were left attached to the uterus with their extraembry-
onic membranes intact. After experimental manipulation of the
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embryo, the mother’s abdominal cavity was flushed with lactated
Ringer’s solution (Travenol) to prevent the exo utero embryos
from drying out or from adhering to other tissues (Muneoka et
al., 1986). The mother then was surgically closed with 5-0 silk
(Ethicon) and allowed to recover. After 1 to 5 days of additional
development, the mother was again anesthetized, killed, and the
embryos removed for analysis. 
Preparation of DiI for microinjection 
All injections were made with an 0.05% solution (w/v) of 1,1-
dioctadecyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate
(DiI, Molecular Probes), made from an 0.5% stock solution in
100% ethanol, diluted immediately before injection 1:10 in 0.3 M
sucrose solution. Micropipets were backfilled with DiI solution
and attached to a picospritzer (General Valve). Both the dye and
the micropipets were maintained at 37oC during the injections to
avoid cold shock to the embryo. 
Whole ectoderm labelling 
The ectoderm of exo utero embryos was labelled by inserting a
micropipet through the decidua capsularis, yolk sac and the
amnion into the amniotic cavity and expelling a small amount of
dye (Fig. 1). To determine if either the injection or the exo utero
technique had any adverse affects on embryonic development, the
experimental embryos were compared with embryos that were
allowed to develop in utero . On the basis of both gross morphol-
ogy and somite number, embryos that developed exo utero were
indistinguishable from embryos that developed in utero .
Because the extraembryonic membranes were left intact
throughout the injection procedure, it was not possible to visual-
ize the embryos and assess their developmental stage at the time
of the injection. The stage at which an embryo was injected was
deduced by extrapolating back from the elapsed time and the stage
at which the embryo was fixed. Because somite development in
the mouse takes approximately 1.5-2 hours per somite pair
(Theiler, 1972), 12 to 18 additional somite pairs would be
expected to form after an additional 24 hours of development.
This estimate of the stage of labelling appeared accurate to within
a range of six somites. Because this injection technique labels the
neuroectoderm only in the regions of the neural tube that have not
undergone neural tube fusion, it also was possible to deduce the
stage of injection by observing which regions of the neural tube
contained dye. Embryos labelled prior to the formation of the 7th
somite (before the fusion of the neural tube begins) contained DiI
label all along the neural tube. In embryos that were labelled after
the formation of the 7th somite, DiI label was not present in the
neural tube at the level of the 4th and 5th somites, where neural
tube fusion begins. Embryos labelled after the formation of the
14th somite contained little or no DiI in the neural tube at the cra-
nial levels. 
To determine the length of time after injection that the dye
remained in the amniotic fluid, several embryos were labelled by
injection of the dye into the amniotic cavity in vitro. In all cases,
the dye was visible at the time of the injection. However, when
the amniotic sac was torn open 4 to 5 minutes after the injection,
the dye was no longer visible in the amniotic fluid. This suggests
that labelling is rapid, occurring transiently only at the time of
injection, rather than continuously throughout the experiment.
Even if dye were to remain in the amniotic cavity, no artifactual
labelling would result, as only the cells of the ectoderm and neu-
roectoderm are in contact with the amniotic fluid during the stages
examined here. Although the mechanism responsible for the dis-
appearance of the dye is unknown, two possible explanations are:
(1) that the dye becomes sequestered into the cell membranes of
the embryo and the extraembryonic structures and/or (2) that dye
precipitates due to the salt content of the amniotic fluid.
Regional labelling of premigratory neural crest cells 
To label neural crest cells at specific cranial levels, a micropipet
was inserted into the developing cranial neural folds of embryos
in culture (using a micromanipulator; Marzhauser). When the pipet
was positioned at the juncture of the neuroectoderm and the ecto-
derm, a small amount of the DiI solution was expelled. The fideli-
tiy of these injections was determined by examining the embryos
both at the time of the injection and at the time of analysis. At
the time of the injection, the labelled site was visible through the
dissecting scope as a small red spot of dye in the tissue. At the
time of fixation, the rostrocaudal extent of the dye within the
neural tube was observed using an epifluorescence microscope.
Only those embryos in which the DiI was contained within a single
region (e.g., the midbrain) both at the time of injection and at the
time of fixation were analyzed. Injections in the hindbrain were
divided into two groups: (1) large injections, in which the dye
spanned two or more rhombomeres; and (2) small injections, in
which the dye was contained within a single rhombomere.
Neural tube labelling 
In embryos that had undergone partial or complete neural fold
fusion in the cranial region, the neural tube was labelled by insert-
ing the micropipet into the lumen of the neural tube at the level
of the midbrain using a micromanipulator. In most cases, enough
dye was expelled to fill the neural tube. 
Embryo culture
Embryos, with their extraembryonic membranes and placenta
attached, were cultured for a total of 24 hours in tissue culture-
treated cell wells (35 mm diameter; Corning) containing 4 ml of
culture medium consisting of 25% rat serum, 25% fetal bovine
serum, 49% DMEM and 1% GPS. The embryos were kept in an
atmosphere of 5% CO2 in air at 37oC. After 12 hours, an addi-
tional 4 ml of culture medium were added to each well.
Cultured embryos were compared with embryos allowed to
develop to similar stages in utero to ascertain if the culture period
itself affected embryonic maturation. On the basis of gross mor-
phology and somite number, embryos cultured for 24 hours
appeared similar to embryos developing in utero. Our results agree
with previous studies that have shown that mouse embryos
develop normally in culture for 24 hours after removal from the
mother (New, 1973, 1977; Sadler, 1979; Sadler and New, 1981).
Histology
Embryos were fixed by immersion in 4% paraformaldehyde/0.25%
Fig. 1. Schematic diagram of the amniotic labelling technique. An
incision is made in the wall of the uterus (U), which is deflected to
allow access to the embryos. The micropipet is inserted through
the decidua capsularis (DC), yolk sac (Y) and the amnion (A) into
the amniotic cavity and a small amount of dye is expelled. The
embryo (E) is labelled for orientation. 
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glutaraldehyde in 0.1 M phosphate buffer (PB) for 3 to 6 hours
at 4oC. They were viewed in whole mount through a filter set
designed for rhodamine using a laser scanning confocal micro-
scope (Biorad MRC 600 on a Zeiss Axiovert microscope). This
allowed the visualization of single focal planes without the inter-
ference of scattered light from outside the plane of focus (Fine et
al., 1988). Embryos were prepared for cryostat sectioning by
washing in 0.1 M PB for 1 hour, followed by soaking in a 15%
sucrose solution for 8 to 12 hours at 4oC. They were embedded
in 15% sucrose and 7.5% gelatin (Oxiod), rapidly frozen in liquid
nitrogen and serially sectioned on a cryostat at 30 microns (HM
500 M, Microm). Sections were coverslipped in gel/mount (Bio-
media Corp.) and viewed on an epifluorescence microscope
equipped with a light-intensifying camera (RCA-SIT) and an
image processing system (Imaging Technologies Series 151),
using the VidIm software package (S. E. Fraser, G. Belford and
J. Stollberg, unpublished data).
Results
Amniotic injection of DiI
Premigratory neural crest cells were labelled by injecting a
solution of DiI into the amniotic cavity of exo utero
embryos on E8. Because DiI partitions into the membranes
of the cells it contacts, injections of DiI into the amniotic
cavity at this stage labelled both the ectodermal and the
neuroectodermal cells. During neurulation, the neural tube
and the neural crest were internalized, leaving the ectoderm
(including the placodes) on the surface of the embryo, until
approximately E9, when the first placodes invaginate. As a
result of this segregation, the only labelled cells present in
the mesenchyme were of neural crest or placodal origin.
Embryos were maintained in the mother for 1 to 5 days. At
the end of this period, the exo utero embryos were removed
from the mother for analysis. Table 1 summarizes the num-
bers of embryos analyzed and the distribution of the DiI-
labelled cells at the level of the first branchial arch; Fig.
9A schematizes the distribution of labelled cells in embryos
for each of the stages examined. The findings are presented
below according to the stages at which the embryos were
labelled with DiI.
Embryos injected during the 0- to 6-somite stage 
At the 6-somite stage, the neural folds have not fused, per-
mitting unhampered access of the DiI to the entire neu-
roectoderm. Embryos labelled prior to the end of the 6-
somite stage and allowed to develop for 4 hours contained
DiI-labelled cells in the ectoderm and neuroectoderm exclu-
sively (Fig. 2). This confirmed that the technique labels only
those cells in contact with the amniotic fluid. In embryos
that developed for 24 hours after the injection, DiI-labelled
cells were observed in the cranial mesenchyme and neu-
roectoderm in regionally distinct patterns (Fig. 3A). At the
level of the forebrain, the DiI-labelled cells formed a sheet
that extended ventrally from the dorsal portion of the neural
tube over the region of the prosencephalon, including the
optic vesicle. Transverse sections through the level of the
optic vesicle revealed that these DiI-labelled cells were
located in the mesoderm between the developing eye and
the diencephalon (Fig. 3C). In the midbrain region, the DiI-
labelled cells were dispersed individually throughout the
mesoderm adjacent to both the ectoderm and the mesen-
cephalon (similar to the pattern shown in Fig. 8B). At the
level of the hindbrain, DiI-labelled cells were observed in
three sub-ectodermal streams that extended from the fusion
point of the neural tube to the distal end of the developing
first, second and third branchial arches (Fig. 3B). 
Embryos allowed to develop for 48 hours after injection
contained DiI-labelled cells throughout the cranial mes-
enchyme at the levels of the forebrain, midbrain and hind-
brain (Fig. 4A), in a pattern similar to that observed 24
hours after injection of DiI. In the forebrain region, DiI-
labelled cells were located between the nasal pit and the
eye. At the level of the midbrain, DiI-labelled cells were
distributed individually throughout the mesenchyme adja-
cent to the mesencephalon. At the rostral hindbrain level,
DiI-labelled cells were located in the region of the devel-
oping trigeminal ganglia and in the first branchial arch (Fig.
4B). At the level of the caudal hindbrain, DiI-labelled cells
were observed in the second and third branchial arches. In
transverse sections taken at the level of the otic vesicle,
DiI-labelled cells were present in the developing nodose
and petrosal ganglia.
Embryos injected during the 7- to 13-somite stage
After the formation of somite 7, neural tube fusion begins
at the level of somites 4 and 5 from where it progresses
both rostrally and caudally. Embryos analyzed 24 hours
after labelling contained DiI-labelled cells at fore- and mid-
brain levels in many of the same locations described for
embryos injected at earlier stages (Fig. 5A). The level of
the caudal hindbrain contained few, if any, DiI-labelled
cells, probably because the neural tube had fused there prior
to the injection. At the level of the rostral hindbrain, the
streams of DiI-labelled cells extended to, but not into, the
first branchial arch. Only a few DiI-labelled cells were
observed in the branchial arches in any of the embryos
injected at this stage. In cross-section, DiI-labelled cells
formed a subectodermal stream extending from the dorsal
portion of the neural tube but stopping short at the level of
the forming trigeminal ganglia (Fig. 5B). 
Forty-eight hours after the injection of DiI, the distribu-
tion of DiI-labelled cells was similar to that observed in
embryos analyzed after 24 hours. Individual DiI-labelled
cells were located in the forebrain and the midbrain regions,
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Table 1. Summary of embryos analyzed after whole
ectoderm labelling
Distribution of labelled cells
at the level of the first
Hours of Numbers of branchial arch
Stage of additional embryos
injection development analyzed DBA PBA TG
0 to 6 somite 24 17 + + +
48 9 + + +
7 to 13 somite 24 15 − + +
48 10 − + +
14+ somite 24 8 − − −
48 6 − − +/−
DBA, distal portion of the branchial arch; PBA, proximal portion of the
branchial arch; TG, trigeminal ganglia.
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including the mesenchyme adjacent to the nasal pit, around
the eye and overlying the mesencephalon. At the level of
the rostral hindbrain, DiI-labelled cells were located at the
level of the trigeminal ganglia but not in the branchial
arches (Fig. 5C). 
Embryos labelled at 14- or more somites
Neural tube fusion in the cranial region is completed at
approximately the 16-somite stage. Embryos labelled after
the formation of somite 14 and allowed to develop for 24
or 48 hours contained only a few DiI-labelled cells in the
cranial mesenchyme. These few cells were adjacent to the
dorsal portion of the neural tube. One embryo, labelled after
the fusion of the neural tube was complete, contained a few
DiI-labelled cells in the trigeminal ganglia. These DiI-
labelled cells probably were of placodal origin since the
neural crest cells are not labelled by amniotic injection after
the fusion of the neural tube. The labelled processes of these
trigeminal ganglia cells could be seen extending from the
ganglia into the first branchial arch (Fig. 5D). 
Long-term survival of embryos injected at E8
In order to identify the final destinations of the cranial
neural crest cells, embryos were labelled by amniotic injec-
tion of DiI on E8 after which they were allowed to develop
for 3 to 5 days before analysis. All of the somites are formed
by embryonic day 11; therefore, it was not possible to
deduce the exact stage at which these embryos were
labelled on the basis of the exact number of somites present
at the time of fixation. In addition, due to the size of the
embryos and the increased opacity of their tissues, it was
not possible to analyze the embryos in whole mount after
embryonic day 11. Therefore, all observation were made
on sectioned material. 
In all of the 22 embryos that were allowed to develop
for 3 or more days after labelling, large numbers of DiI-
labelled cells were observed in the trigeminal, the superior,
the jugular, the nodose and the petrosal ganglia (Fig. 6 ).
DiI-labelled cells also were observed in several neural tube-
derived structures, including the olfactory bulb and the optic
stalk. Unlike the neural derivatives, the mesenchymal deriv-
atives of the neural crest contained only a few detectable
DiI-labelled cells in embryos examined at E11 and no
detectable DiI-labelled cells at later stages. This probably
was due to dilution of the dye by the extensive cell divi-
sion in the mesenchymal derivatives. 
Regional labelling
In order to confirm the above results and to examine axial
differences in the migration of cranial neural crest cells,
subsets of the neural crest were labelled by focally inject-
ing small amounts of DiI into the juncture of the neuroec-
toderm and the ectoderm. To permit adequate visualization
and control of the injection site, these injections were per-
formed in culture. In addition, this allowed the exact stage
of the embryo at the time of injection to be determined.
Two types of injections were made: (1) larger injections,
which labelled most or all of a particular region (e.g. the
entire midbrain or forebrain) and (2) smaller injections,
which labelled relatively few cells and were contained
within a specific region (e.g. in the hindbrain injection sites
were contained within a single rhombomere). By virtue of
their position, these injections labelled both the neural crest
cell precursors within the neural fold and the newly emerg-
Fig. 4. Embryos labelled by amniotic injection of DiI at the 0- to 6-somite stage and maintained exo utero for 48 hours. (A) In this
fluorescent confocal image, DiI-labelled cells were located between the nasal pit (N) and the eye (E). At the level of the midbrain,
individual DiI-labelled cells were observed throughout the mesenchyme adjacent to the mesencephalon. At the level of the rostral
hindbrain, DiI-labelled cells (arrow) were observed in the region of the developing trigeminal ganglia (T) and the first branchial arch (1),
as well as in the first and second branchial arches (1 and 2). (B) In transverse sections through the level of myelencephalon (MY), DiI-
labelled cells were observed within the developing trigeminal ganglia and in the first branchial arch (arrow). Bars: A, 375 μm; B, 50 μm.
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ing neural crest cells. Following injection, embryos were
cultured for 24 hours before analysis. Table 2 summarizes
the number of embryos analyzed and the presence of
labelled cranial neural crest cells outside the neural tube;
from these data, the stages when cells emigrate from the
different axial levels of the neural crest were deduced (Fig.
9B). Table 3 summarizes the number of embryos that
recieved injections into individual rhombomeres.
Embryos injected at the 0- to 5-somite stage
Before the 5-somite stage, focal injections of DiI at any
cranial level resulted in labelled cells in the cranial mes-
enchyme. With injections at the level of the forebrain, DiI-
labelled cells were found a short distance from the neural
tube toward the developing eye. Injections into the mid-
brain gave rise to dispersed labelled cells in the mes-
enchyme overlying the mesencephalon (Fig. 7A). Injections
into the rostral hindbrain produced a stream of cells extend-
ing from the neural tube toward the developing first
branchial arch (Fig. 7B). At the level of the caudal hind-
brain, injections gave rise to a stream of labelled cells that
extended into the second or the third branchial arch. For
example, injections slightly caudal to the level of the otic
vesicle gave rise to a stream of labelled cells extending into
the third branchial arch (Fig. 7C). The distribution of
labelled cells in each region was similar to that observed
in embryos labelled by amniotic injection at comparable
stages.
Embryos injected at the 6- to 10-somite stage
All focal injections at this stage produced DiI-labelled cells
that migrated away from the site of the injection. Injections
at the level of the forebrain gave rise to DiI-labelled cells
in the region of the developing eye. Embryos labelled at
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Fig. 5. Embryos labelled by amniotic injection of DiI at the 7- to
13-somite stage and maintained exo utero for 24 and 48 hours. (A)
After 24 hours, embryos contained a sheet of DiI-labelled cells
extending temporally from the dorsal portion of the neural tube in
the forebrain, over the prosencephalon (P) toward the developing
eye (E). In the midbrain region, DiI-labelled cells were dispersed
throughout the mesenchyme overlying the mesencephalon. In the
hindbrain, DiI-labelled cells were present in the dorsal portion of
the branchial arches (1 and 2), in the region of the presumptive
trigeminal ganglion (arrow), and in the region overlying the
mesencephalon. (B) A transverse section through the level of the
first branchial arch and the myelencephalon (MY) contains DiI-
labelled cells in the developing trigeminal ganglia (arrows). (C)
Embryos that developed for 48 hours after the injection contained
DiI-labelled cells in the mesenchyme adjacent to the nasal pit (N),
around the eye (E) and overlying the mesencephalon. At the level
of the rostral hindbrain, DiI-labelled cells were located in the
trigeminal ganglia (T) and the dorsal portion of the branchial
arches (1 and 2). (D) An embryo labelled by amniotic injection of
DiI at the 14+ somite stage after fusion of the neural tube was
completed up to the level of the midbrain, contained DiI-labelled
cells in the trigeminal ganglia and DiI-labelled processes (arrow)
extending from the trigeminal ganglion (T) into the first branchial
arch. The eye (E), the trigeminal ganglion (T), the nasal pit (N),
the prosencephalon (P), the myelencephalon (MY) and the first
and second branchial arches (1 and 2) are indicated for
orientation. Bars: A, 100 μm; B, 50 μm; C, D, 200 μm.
Table 2. Summary of embryos analyzed 24 hours after
regional or neural tube labelling
Number of Migrating
Stage at time embryos cells
of injection analyzed observed
Forebrain labelling 0 to 5 somite 5 +
6 to 10 somite 10 +
11 to 15 somite 11 +
16+ somite 8 +/−
Midbrain labelling 0 to 5 somite 10 +
6 to 10 somite 12 +
11 to 15 somite 9 +/−
16+ somite 3 −
Rostral hindbrain 0 to 5 somite 7 +
labelling 6 to 10 somite 13 +
11 to 15 somite 10 −
16+ somite 4 −
Caudal hindbrain 0 to 5 somite 5 +
labelling 6 to 10 somite 11 +
11 to 15 somite 10 +/−
16+ somite 6 −
Table 3. Summary of embryos analyzed after individual
rhombomere labelling
Stage of
injection r1 r2 r3 r4 r5 r6 r7 r8
6 to 10 3 3 2 1 NA 2 3 2
somite
11 to 15 NA 4 1 2 2 1 2 2
somite
r, rhombomere.
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the level of the midbrain contained dye-labelled cells in the
mesenchyme between the mesencephalon and the ectoderm
(Fig. 8A and B). Focal injections into the region of the
neural tube which will develop into the 1st or 2nd rhom-
bomeres (r1 or r2) produced a stream of DiI-labelled cells
that extended from the site of the injection to the level of
the first branchial arch. Injections into r3, r4 or r5 gave rise
to labelled cells extending from the dorsal portion of the
neural tube into the second branchial arch (Fig. 8C). Injec-
tions into r6, r7 or r8 gave rise to a stream of cells extend-
ing from the injection site toward the third, and possibly
the fourth branchial arch. 
Embryos injected at the 11- to 15-somite stage
Before the 14-somite stage, injections at the level of the
forebrain, midbrain or r2-8 gave similar patterns of DiI-
labelled cells to those described above. In contrast, embryos
injected at the level of rhombomere 1 contained no DiI-
labelled cells outside the injection site (Fig. 8D), suggest-
ing that all of the neural crest cells at the level of the first
rhombomere had completed emigration by the 10-somite
stage. After the 14-somite stage, DiI injections at the level
of the midbrain, or r2-8 no longer gave rise to labelled cells
outside the injection site, suggesting that emigration from
these axial levels was completed by the 14-somite stage. In
contrast, at the level of the forebrain, emigration continued
through the 14- and 15-somite stage. 
Embryos injected at the 16+ somite stage
Embryos that were labelled at the levels of the forebrain,
midbrain or hindbrain after the formation of somite 16 con-
tained no DiI-labelled cells outside the site of injection. 
Neural tube labelling
At approximately the 16-somite stage, neural tube fusion is
complete, or nearly complete, in the head of the mouse.
Therefore, it was possible to label the cells of the neural
tube, including any premigratory neural crest cells, by
injecting DiI into the lumen of the neural tube of embryos
in culture (Serbedzija et al., 1990). Embryos were labelled
by intraluminal injection of DiI and then cultured for 24
hours before analysis. The neural tube at the level of the
forebrain, midbrain and hindbrain contained DiI-labelled
cells. However, only those embryos that were labelled prior
to the formation of somite 16 contained DiI-labelled cells
outside the neural tube and these were found only at the
level of the forebrain.
Discussion
DiI labelling of premigratory and migratory neural crest
cells in exo utero and cultured mouse embryos provided a
direct assay of the pattern and timing of cranial neural crest
cell migration. Three distinct patterns of cranial neural crest
Fig. 9. (A) Schematic representation of the location of DiI-labelled cells after amniotic injection of DiI into progressively older embryos.
Light gray represents the distribution of DiI-labelled cells in embryos injected at early stages of migration (0- to 6-somite stage). At the
level of the forebrain, a sheet of DiI-labelled cells is observed that extends ventrally from the dorsal portion of the neural tube to
encompass the developing eye (E). At the level of the midbrain, individual DiI-labelled cells are dispersed over the mesencephalon (M).
At the level of the rostral hindbrain, DiI-labelled cells are observed in a stream, which extended from the fusion point of the neural tube to
the distal end of the developing first branchial arch (1). In the caudal region of the hindbrain, a stream of DiI-labelled cells is observed
extending into the second arch (2). Embryos injected at slightly later stages (7- to 10-somite stage) contain DiI-labelled cells in similar
locations; however, the cells do not extend as far ventrally (medium gray). Embryos labelled at late stages of migration (11- to 16-somite
stage) contain DiI-labelled cells only along the dorsal portion of the head (dark gray). Embryos labelled after cranial neural crest cell
emigration is complete contain DiI-labelled cells only in the neural tube (black). (B) Schematic representation of the pattern in which
neural crest cells stop emigrating from the neural tube. By the 11-somite stage, DiI-labelled cells no longer emigrate from the region of
the rostral midbrain (black). DiI-labelled cells in the midbrain and caudal hindbrain stop emigrating from the neuroectoderm by the 14-
somite stage (dark gray). In the forebrain, emigration of DiI-labelled cells ends at the 16-somite stage (light gray). The prosencephalon
(P), mesencephalon (M), eye (E), otic vesicle (OV), trigeminal ganglion (T), first (1) and second (2) branchial arches and heart (H) are
labelled for orientation. 
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cell migration were observed. Neural crest cells from the
level of the forebrain migrated ventrally through the mes-
enchyme in a sheet extending from the dorsal portion of
the neural tube to the level of the optic vesicle and popu-
lated the mesenchyme around the eye. In contrast, neural
crest cells at the level of the midbrain appeared to migrate
ventrolaterally as dispersed cells through the mesenchyme
between the lateral surface of the mesencephalon and the
ectoderm. These cells populated the region overlying the
mesencephalon. At the level of the hindbrain, neural crest
cells migrated ventrolaterally along three segmentally dis-
tributed subectodermal streams, from the dorsal portion of
the neural tube to the distal portion of the first, second and
third branchial arches. In addition to the branchial arches,
these cells populated the trigeminal, superior, jugular, pet-
rosal and nodose ganglia. 
The order in which neural crest cells populated their
derivatives was determined by labelling embryos at differ-
ent stages of development. Injection of DiI into the amni-
otic cavity labelled only cells that are continuous with the
G. N. Serbedzija, M. Bronner-Fraser and S. E. Fraser
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neuroectoderm and migratory neural crest cells are left
unlabelled; making it possible to mark temporally distinct
subsets of the neural crest cells. Because of the dramatic
changes in the anatomy of the head during these stages of
development, the order in which cranial neural crest cells
populated their derivatives was best illustrated at the level
of the rostral hindbrain. Embryos labelled during the earli-
est stages of neural crest cell migration contained DiI-
labelled cells throughout the first branchial arch, as well as
in the region of the trigeminal ganglia (Fig. 9B, light gray).
In contrast, embryos labelled at slightly later stages con-
tained DiI-labelled cells at the level of the trigeminal gan-
glia, but not in the first branchial arch (Fig. 9B, medium
gray). Embryos labelled at still later stages contained DiI-
labelled cells adjacent to the dorsal portion of the neural
tube, but not at the level of the trigeminal ganglia or in the
first branchial arch (Fig. 9B, dark gray). Therefore, cranial
neural crest cells populated their derivatives in a ventral-
to-dorsal order, similar to that observed for neural crest cells
in the trunk (Serbedzija et al ., 1990). 
Previous studies, using either ultrastructural characteris-
tics (Nichols, 1981, 1986) or topical wheat germ agglutinin
labelling (Chan and Tam, 1988) to identify neural crest
cells, indicated that neural crest cell migration begins at
approximately the 5-somite stage in the rostral hindbrain
(Nichols, 1981, 1986; Chan and Tam, 1988). Emigration
follows in the midbrain, the caudal hindbrain and finally
the forebrain (Nichols, 1981). These previous studies also
suggested that neural crest cell emigration at the rostral
hindbrain level is complete by the 10-somite stage. By
labelling premigratory neural crest cells with DiI at pro-
gressively later stages of development, we were able to
make a direct determination of the stages at which neural
crest cells cease emigrating from the neural folds not only
at the level of the rostral hindbrain but also at each of the
other axial levels (Fig. 9B). Focal injections of DiI into the
juncture of the neuroectoderm and the ectoderm labelled
both the neural crest cell precursors within the neural fold
and the newly emerging neural crest cells. In the most ros-
tral hindbrain (r1), neural crest cells ceased to emigrate
from the neural folds by the 11-somite stage. In the mid-
brain and caudal hindbrain regions, neural crest cell emi-
gration from the neural folds ended by the 14-somite stage.
In the forebrain, however, neural crest cell emigration from
the neural folds continued until the 16-somite stage.
Because the DiI-labelling technique marks both emigrating
and soon-to-emigrate neural crest cells, it is difficult to
determine exactly the time of initiation of neural crest emi-
gration by this method. However, the previous ultrastruc-
tural studies (Nichols, 1981, 1986) were well-suited to
determining the stage of neural crest emigration, and gen-
erated results consistent with our own. By combining the
data from these various approaches, it was possible to
deduce the duration of neural crest cell emigration at each
axial level. Neural crest cell emigration from the rostral
hindbrain begins at the 5-somite stage and ends by the 10-
somite stage, approximately 9 hours later. At other axial
levels, the timing of initiation of migration and cessation
of emigration paralleled one another, suggesting that the
duration of cranial neural crest cell emigration at all axial
levels was approximately 9 to 12 hours. 
The final destinations of the DiI-labelled cranial neural
crest cells were examined by allowing some of the embryos
labelled by amniotic injection on E8 to develop for an addi-
tional 3 to 5 days. DiI-labelled cells were found in all of
the neuronal derivatives of the cranial neural crest, includ-
ing the trigeminal, the superior, the jugular, the nodose and
the petrosal ganglia. Surprisingly, no DiI-labelled cells were
detected in any of the mesenchymal derivatives after E11,
even though DiI-labelled cells were observed in the mes-
enchymal derivatives of embryos examined 1 to 2 days after
the injection. Because a fixed amount of DiI was injected,
the dye could have been diluted by extensive cell division.
Fig. 10. Schematic representations showing the pathways of
neural crest cell migration in the mouse, chick and rat embryos.
Because the labelling and the data analysis techniques varied for
each of the species represented here, a small amount of artistic
license was used for the sake of comparison. Light gray represents
neural crest cells that migrate through the mesenchyme. Dark gray
represents neural crest cells that migrate along subectodermal
pathways. (A-C) Whole embryo view showing the origins and
overall pathways of neural crest cell migration. (A) In the mouse
embryo there are three regionally distinct pathways of neural crest
cell migration. Neural crest cells from the level of the forebrain
migrate ventrally in a sheet extending from the dorsal portion of
the neural tube to the level of the eye (E). Neural crest cells from
the level of the midbrain migrate ventrolaterally toward the
maxillary process and the eye (E). At the level of the hindbrain,
neural crest cells migrate ventrolaterally in three streams, from the
dorsal portion of the neural tube to the distal portion of the first
(1), second (2) or third (3) branchial arches. (B) In the chick
embryo, only the midbrain and hindbrain give rise to cranial
neural crest cells. Neural crest cells from the level of the midbrain
migrate ventrolaterally toward the maxillary process and the eye
(E) and rostrally toward the nasal process (N). At the level of the
hindbrain, neural crest cells migrate ventrolaterally in three
streams, from the dorsal portion of the neural tube to the distal
portion of the first (1), second (2) or third (3) branchial arches. (C)
In the rat, migratory neural crest cells arise at the level of the
midbrain and hindbrain. However, it is not clear whether or not
migratory neural crest cells arise from the level of the forebrain.
At the level of the midbrain, neural crest cells migrate
ventrolaterally toward the maxillary process and the eye (E).
Neural crest cells from the hindbrain migrate ventrolaterally in
three streams extending from the dorsal portion of the neural tube
to the distal portion of the first (1), second (2) or third (3)
branchial arches. (D-F) A cross-sectional view through the level
of the eye. (D) In the mouse, neural crest cells from both the
midbrain and the forebrain migrate through the mesoderm. In
addition, neural crest cells from the forebrain migrate between the
eye (E) and the forebrain (F). (E) In the chick, neural crest cells
migrate along a subectodermal pathway from the dorsal portion of
the midbrain neural tube (M) to the eye (E). (F) In the rat, neural
crest cells migrate through the mesenchyme from the dorsal
portion of the midbrain neural tube (M) toward the eye (E). (G-I)
A cross-sectional view through the level of the first branchial arch.
(G and H) In the mouse and the chick, neural crest cells migrate
along a subectodermal pathway that extends from the neural tube
into the first branchial arch. (I) in the rat, neural crest cells migrate
through the mesenchyme as dispersed cells from the neural tube
into the first branchial arch. The forebrain (F), midbrain (M),
rostral hindbrain (RH), eye (E), notocord (N), otic vesicle (OV),
trigeminal ganglion (T), first (1), second (2), third (3) branchial
arches and heart (H) are labelled for orientation.
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Consistent with this possibility, cranial ganglion cells in
avians do not undergo extensive division (see review by Le
Douarin, 1982), while the cells that contribute to the mes-
enchymal derivatives of the cranial neural crest proliferate
extensively (Noden, 1988).
Cranial neural crest cells in the region of the hindbrain
migrate in a segmented pattern that corresponds to the loca-
tion of the branchial arches. This pattern consists of three
separate streams of cells, lateral to r2, r4 and r6, each of
which extends from the neural tube into the adjacent
branchial arch. The high degree of segmentation in the hind-
brain that becomes apparent at later stages might suggest
that the formation of the neural crest also may be seg-
mented, directly contributing to this pattern. For example,
the streams at r2, r4 and r6 might be created by the failure
of other axial levels of the neural tube (e.g. r3 and r5) to
give rise to migrating neural crest cells, similar to the pat-
tern recently reported to occur in avians (Lumsden et al.,
1991). However, injections of DiI into the mouse neural
crest at each level of the hindbrain, from rhombomere 1
through 8, gives rise to labelled cells outside the neural
tube. In addition, recent experiments suggest that there may
be a small, but significant contribution of neural crest cells
from r3 and a large contribution from r5 in the avian
embryo as well (J. Sechrist, G. N. Serbedzija, S. E. Fraser,
T. Scherson and T. Bonner-Fraser, unpublished data). This
casts doubt on the simple hypothesis that segmented migra-
tion reflects segmental origin and suggests that the seg-
mented pattern of mouse neural crest cell migration at the
level of the hindbrain may be imposed by factors extrinsic
to the neural tube, as is the case for the relationship between
trunk neural crest cells and the somitic mesenchyme (Bron-
ner-Fraser and Stern, 1991).
Although the DiI-labelling technique permits defined
groups of cells to be marked, it does have some limitations.
First, because the intra-amniotic injection labels the whole
ectoderm, the ectodermal placodes also are labelled.
Because the placodes contribute to the cranial ganglia, the
possibility exists that some of the labelled cells found in
the mesenchyme are of placodal rather than neural crest
origin (see Fig. 5D). Second, this technique does not permit
the analysis of cranial neural crest cell emigration from
regions where the neural tube has fused. To minimize these
potential pitfalls and to confirm the results, embryos in cul-
ture were labelled by small injections of DiI into specific
axial levels of the neural tube. The results from this regional
labelling are consistent with the results obtained with the
whole ectoderm labelling, suggesting that the whole ecto-
derm labelling approach gives a realistic view of neural
crest cell migration in the mouse embryo. 
The pattern described here for mouse cranial neural crest
cell migration shares some, but not all, characteristics with
the patterns described for both chick and rat neural crest
cell migration. At the level of the hindbrain, mouse and
chicken cranial neural crest cells migrate ventrolaterally
along three subectodermal streams that extend from the
neural tube into each branchial arch (Fig.10A, B, G and H;
Chan and Tam, 1988; Lumsden et al., 1991). In the rat,
neural crest cells from the level of the hindbrain appear to
migrate through the mesenchyme as dispersed cells (Fig.
10C and I; Tan and Morriss-Kay, 1986). At the midbrain
level, neural crest cells of the mouse and rat migrate through
the mesenchyme (Fig. 10A, C, D and F), while chick neural
crest cells migrate along more superficial subectodermal
pathways (Fig. 10B and E; Le Douarin, 1982; Tan and Mor-
riss-Kay, 1986; Noden, 1988). At the level of the forebrain,
we find that mouse embryos do have emigrating neural crest
cells in support of previous ultrastructural results (Fig. 10
A and D; Nichols, 1986); in contrast, neither chick nor rat
embryos appear to have a contribution from the forbrain to
the cranial neural crest cells (Fig. 10B, C, E and F; John-
ston, 1966; Noden, 1975; Tan and Morriss-Kay, 1985).
Some of these apparent differences may be due to the dif-
ferent labelling techniques and analytical approaches used
to study neural crest cell migration in each of the three
species. Further comparative analyses of apparent similar-
ities and differences of neural crest cell behavior in these
three species may provide insights into the mechanisms that
control the development and migration of cranial neural
crest cells.
In summary, by labelling premigratory cranial neural
crest cells with DiI, the patterns and timing of cranial neural
crest cell migration in the mouse were determined. Our
observations confirm and extend the observations of both
ultrastructural (Nichols, 1981, 1986) and topical labelling
studies (Chan and Tam, 1988). Because our approach per-
mitted the labelling of embryos in vivo rather than in cul-
ture, it circumvents many of the potential difficulties
encountered in previous studies (Nichols, 1981, 1986; Chan
and Tam, 1988) and allows the analysis of neural crest cell
migration over much more extended periods of develop-
ment than previously possible. The use of DiI-labelling in
intact embryos has permitted, for the first time, direct analy-
ses of the migration pathways, the duration of emigration
and the order of contribution to derivatives of the mouse
cranial neural crest. By defining the normal pattern of cra-
nial neural crest cell migration, the results presented here
provide a solid foundation for further experimental analy-
sis of the factors affecting both neural crest cell migration
and differentiation. This approach does not require specific
mouse strains; furthermore, it can be applied to a variety
of species. Future experiments using DiI-labelling to define
the spatial and temporal aspects of neural crest migration
in genetically manipulated embryos should permit decisive
test experiments and provide new insights about the mech-
anisms of neural crest cell migration and differentiation in
higher vertebrates.
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